Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Kaminski

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Pain|September 1, 1992
An effect of ascorbic acid on delayed-onset muscle sorenessMark Kaminski, Robert Boal
Theory of Computing Systems|July 2, 2019
Complexity and Expressive Power of Weakly Well-Designed SPARQLMark Kaminski, Egor V Kostylev
Hematology. American Society of Hematology. Education Program|November 10, 2001
Managing Indolent Lymphomas in Relapse: Working Our Way Through a Plethora of OptionsFernando Cabanillas, Sandra Horning, Mark Kaminski, et al.
Cancer Research|February 19, 2008
Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14Peter Ouillette, Harry Erba, Lisa Kujawski, et al.
Blood|April 26, 2008
Genomic complexity identifies patients with aggressive chronic lymphocytic leukemiaLisa Kujawski, Peter Ouillette, Harry Erba, et al.
Blood|November 1, 2007
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemiaChris Saddler, Peter Ouillette, Lisa Kujawski, et al.
Blood|July 29, 2011
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemiaPeter Ouillette, Roxane Collins, Sajid Shakhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
A pathobiological role of the insulin receptor in chronic lymphocytic leukemiaKamlai Saiya-Cork, Roxane Collins, Brian Parkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2021
Follicular Lymphoma-associated BTK Mutations are Inactivating Resulting in Augmented AKT ActivationNan Hu, Fangyang Wang, Tianyu Sun, et al.
The Lancet. Haematology|September 21, 2019
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trialAsra Ahmed, Samuel A Merrill, Fares Alsawah, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Pain|September 1, 1992
An effect of ascorbic acid on delayed-onset muscle sorenessMark Kaminski, Robert Boal
Theory of Computing Systems|July 2, 2019
Complexity and Expressive Power of Weakly Well-Designed SPARQLMark Kaminski, Egor V Kostylev
Hematology. American Society of Hematology. Education Program|November 10, 2001
Managing Indolent Lymphomas in Relapse: Working Our Way Through a Plethora of OptionsFernando Cabanillas, Sandra Horning, Mark Kaminski, et al.
Cancer Research|February 19, 2008
Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14Peter Ouillette, Harry Erba, Lisa Kujawski, et al.
Blood|April 26, 2008
Genomic complexity identifies patients with aggressive chronic lymphocytic leukemiaLisa Kujawski, Peter Ouillette, Harry Erba, et al.
Blood|November 1, 2007
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemiaChris Saddler, Peter Ouillette, Lisa Kujawski, et al.
Blood|July 29, 2011
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemiaPeter Ouillette, Roxane Collins, Sajid Shakhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
A pathobiological role of the insulin receptor in chronic lymphocytic leukemiaKamlai Saiya-Cork, Roxane Collins, Brian Parkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2021
Follicular Lymphoma-associated BTK Mutations are Inactivating Resulting in Augmented AKT ActivationNan Hu, Fangyang Wang, Tianyu Sun, et al.
The Lancet. Haematology|September 21, 2019
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trialAsra Ahmed, Samuel A Merrill, Fares Alsawah, et al.
Pageof 2